Is ARCT or ARMP more undervalued in 2026?

CirclFi compares Arcturus Therapeutics Holdings (ARCT) and Armata Pharmaceuticals, Inc. (ARMP) using 13 institutional-grade valuation models. ARCT has a Quality of Company score of 6.7/10 while ARMP scores 3.5/10.

Which is a better buy — ARCT or ARMP?

Compare intrinsic values from 13 independent models against current market prices. CirclFi also calculates Value Trap scores. This is not financial advice — conduct your own analysis.

How do ARCT and ARMP valuations compare?

ARCT at $7.92 and ARMP at $8.12 are compared across Bayesian DCF, EPV, EROIC Spread, First Chicago, Markov DDM, and 8 additional models.

ARCT vs ARMP Valuation Comparison 2026 — Intrinsic Value Analysis

ARCT

Biotechnology

Arcturus Therapeutics Holdings

Quality

6.7

out of 10

Value Trap

SAFE

Price

$7.92

Last close

Models

10/13

Active

ARMP

Biotechnology

Armata Pharmaceuticals, Inc.

Quality

3.5

out of 10

Value Trap

SAFE

Price

$8.12

Last close

Models

7/13

Active

Model-by-Model Comparison

Model	Type	ARCT Fair Value	ARCT Upside	ARMP Fair Value	ARMP Upside
Bayesian DCF	Intrinsic	$5.25	-33.8%	$1.04	-87.2%
First Chicago	Scenario	$•••.••	••.•%	$•••.••	••.•%
ML-RIV	Intrinsic	$1.95	-72.2%	$0.87	-89.5%
Dynamic NAV	Asset-Based	$•••.••	••.•%	$•••.••	••.•%
PWERM	Option-Based	$8.50	+7.3%	$15.46	+90.4%
Regime Cross-Sectional	Relative	$•••.••	••.•%	$•••.••	••.•%
Sentiment SOTP	Hybrid	$•••.••	••.•%	$•••.••	••.•%
CUCE Ensemble	Ensemble	$•••.••	••.•%	$•••.••	••.•%
FTNN Topology	Relative	$•••.••	••.•%	$•••.••	••.•%
RCMH-DCF	Intrinsic	$•••.••	••.•%	$•••.••	••.•%

🔒

Unlock Full 13-Model Comparison

Access all valuation models for ARCT vs ARMP — including EROIC Spread, First Chicago, Markov DDM, PWERM, and 7 more.

Access Full Analysis — From $27/mo →

ARCT vs ARMP — Which Stock Is More Undervalued?

ARCT scores higher with a 6.7/10 quality rating vs ARMP's 3.5/10. Both stocks are analyzed daily using SEC EDGAR filings across 13 independent models.

Comparing Arcturus Therapeutics Holdings (ARCT) and Armata Pharmaceuticals, Inc. (ARMP) across 13 institutional-grade valuation models reveals how each company's intrinsic value stacks up against its market price. CirclFi's engine processes SEC EDGAR 10-K and 10-Q filings, FRED macroeconomic data, and GDELT news sentiment to generate independent fair value estimates daily.

ARCT currently trades at $7.92 with a QOC of 6.7/10, while ARMP trades at $8.12 with a QOC of 3.5/10.

Both companies are analyzed with models spanning intrinsic (Bayesian DCF, EPV), scenario-based (First Chicago), regime-switching (Markov DDM, RCMH-DCF), machine learning (ML-RIV, FTNN Topology), and ensemble methods (CUCE).